[HTML][HTML] Transplantation of photoreceptors into the degenerative retina: Current state and future perspectives

SJ Gasparini, S Llonch, O Borsch, M Ader - Progress in retinal and eye …, 2019 - Elsevier
The mammalian retina displays no intrinsic regenerative capacities, therefore retinal
degenerative diseases such as age-related macular degeneration (AMD) or retinitis …

Viral vectors for gene delivery to the nervous system

BL Davidson, XO Breakefield - Nature Reviews Neuroscience, 2003 - nature.com
Our ability to manipulate the genetic constitution of the nervous system has come of age with
various technologies, including virus vectors that can efficiently deliver genes to neurons …

Clinical applications of retinal gene therapy

DM Lipinski, M Thake, RE MacLaren - Progress in retinal and eye research, 2013 - Elsevier
Many currently incurable forms of blindness affecting the retina have a genetic etiology and
several others, such as those resulting from retinal vascular disturbances, respond to …

Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers

L Pitkänen, M Ruponen, J Nieminen, A Urtti - Pharmaceutical research, 2003 - Springer
Purpose. To investigate the role of vitreous in nonviral gene delivery into retinal pigment
epithelial (RPE) cells. Methods. Human RPE cell line D407 was cultured in six-well plates …

AAV-mediated gene therapy for retinal disorders: from mouse to man

PK Buch, JW Bainbridge, RR Ali - Gene therapy, 2008 - nature.com
A wide range of retinal disorders can potentially be treated using viral vector-mediated gene
therapy. The most widely used vectors for ocular gene delivery are based on adeno …

Looking into the future: Gene and cell therapies for glaucoma

AM Komáromy, KL Koehl, SA Park - Veterinary ophthalmology, 2021 - Wiley Online Library
Glaucoma is a complex group of optic neuropathies that affects both humans and animals.
Intraocular pressure (IOP) elevation is a major risk factor that results in the loss of retinal …

Gene therapy and transplantation in CNS repair: the visual system

AR Harvey, Y Hu, SG Leaver, CB Mellough… - Progress in retinal and …, 2006 - Elsevier
Normal visual function in humans is compromised by a range of inherited and acquired
degenerative conditions, many of which affect photoreceptors and/or retinal pigment …

Novel insights into gene therapy in the cornea

RR Mohan, LM Martin, NR Sinha - Experimental eye research, 2021 - Elsevier
Corneal disease remains a leading cause of impaired vision world-wide, and advancements
in gene therapy continue to develop with promising success to prevent, treat and cure …

Challenges and strategies for the delivery of biologics to the cornea

M Wels, D Roels, K Raemdonck, SC De Smedt… - Journal of Controlled …, 2021 - Elsevier
Biologics, like peptides, proteins and nucleic acids, have proven to be promising drugs for
the treatment of numerous diseases. However, besides the off label use of the monoclonal …

Open-angle glaucoma: therapeutically targeting the extracellular matrix of the conventional outflow pathway

J O'Callaghan, PS Cassidy… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: Ocular hypertension in open-angle glaucoma is caused by a reduced rate of
removal of aqueous humour (AH) from the eye, with the majority of AH draining from the …